Product Information
AZITHROMYCIN 600 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.7148 per EA under NDC 62332025330. Its NADAC has been published 252 times since Nov 3, 2021.
FDA first approved this application on Jan 27, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332025330
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AZITHROMYCIN DIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA211793FDA Approved
1/27/2020
TE Code
AB
On Market Since
1/28/2020
Pharmacological Classes
Price Statistics
The NADAC for AZITHROMYCIN 600 MG TABLET has been published 252 times since Nov 3, 2021, and over the history we have for it it has declined 33.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7148 per EA |
|---|---|
| All-time high | $1.5251 (Feb 11, 2026) |
| All-time low | $0.6140 (Jun 19, 2024) |
| 52-week high | $1.5251 |
| 52-week low | $0.7148 |
| Median price | $1.0817 |
| Average price | $1.0195 |
| Largest weekly change | -39.1% (Mar 22, 2023) |
| Weeks tracked | 252 |
| Tracking since | Nov 3, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the AZITHROMYCIN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
AZITHROMYCIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AZITHROMYCIN 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AZITHROMYCIN 600 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.7148 per EA (NDC 62332025330), effective Sep 30, 2026.
How has the price of AZITHROMYCIN 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for AZITHROMYCIN 600 MG TABLET has declined 33.9%. It has been tracked across 252 weekly CMS publications since Nov 3, 2021.
What are the highest and lowest recorded NADAC prices for AZITHROMYCIN 600 MG TABLET?
Since Nov 3, 2021, the NADAC for AZITHROMYCIN 600 MG TABLET has ranged from a low of $0.6140 (Jun 19, 2024) to a high of $1.5251 (Feb 11, 2026), with a median of $1.0817 per EA.
Are there cheaper alternatives to AZITHROMYCIN 600 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of AZITHROMYCIN 600 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AZITHROMYCIN 600 MG TABLET?
AZITHROMYCIN 600 MG TABLET (NDC 62332025330) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.